New Syndromes,
De novo variants in WDR37 are associated with epilepsy, colobomas, dysmorphism, developmental delay, intellectual disability, and cerebellar hypoplasia
- Am J Hum Genet. 2019 Aug 1;105(2):413-424
De novo missense variants in WDR37 cause a severe multisystemic syndrome
- Am J Hum Genet. 2019 Aug 1;105(2):425-433
De novo variants disturbing the transactivation capacity of POU3F3 cause a characteristic neurodevelopmental disorder
- Am J Hum Genet. 2019 Aug 1;105(2):403-412
Biallelic variant in AGTPBP1 causes infantile lower motor neuron degeneration and cerebellar atrophy
- Am J Med Genet A. 2019 Aug;179(8):1580-1584
New Genes
Brittle Hair phenotype is caused by bi-allelic TARS mutations
- To read more about “Trichothiodystrophy”
- Am J Hum Genet. 2019 Aug 1;105(2):434-440
Microcephalic primordial dwarfism is caused by biallelic variants in DNA2
- To read more about “Microcephalic primordial dwarfism”
- Hum Mutat. 2019 Aug;40(8):1063-107
Cerebellar degeneration and motor neuropathy is caused by biallelic variants in AGTPBP1, involved in tubulin deglutamylation
- To read more about “Pontocerebellar hypoplasia type 1”
- Eur J Hum Genet. 2019 Sep;27(9):1419-1426
Muscle-specific cytochrome c oxidase deficiency is caused by COX6A2 variants
- To read more about “Isolated cytochrome C oxidase deficiency”
- Ann Neurol. 2019 Aug;86(2):193-202
A heterozygous, intragenic deletion of CNOT2 recapitulates the phenotype of 12q15 deletion syndrome
- To read more about “12q15q21.1 microdeletion syndrome”
- Am J Med Genet A. 2019 Aug;179(8):1615-1621
Autism and developmental disability caused by KCNQ3 gain-of-function variants
- Ann Neurol. 2019 Aug;86(2):181-192
Clinical Research
Muenke syndrome: A large cohort study evaluated medical and surgical comorbidities and long-term management
- To read more about “Muenke syndrome”
- Am J Med Genet A. 2019 Aug;179(8):1442-1450
Prader-Willi syndrome: A study showed that growth hormone therapy may influence intelligence impacted by Prader-Willi genetic subtypes
- To read more about “Prader-Willi syndrome”
- Am J Med Genet A. 2019 Sep;179(9):1826-1835
Beckwith-Wiedemann syndrome: A study evaluating phenotype evolution and health issues showed that adult health conditions are mostly consequent to pediatric issues, underlying the preventive role of follow-up strategies in childhood
- To read more about “Beckwith-Wiedemann syndrome”
- Am J Med Genet A. 2019 Sep;179(9):1691-1702
Systemic lupus erythematosus: A study showed that lower scores of SF-36 physical function independently predicted mortality
- To read more about “Systemic lupus erythematosus”
- https://www.ncbi.nlm.nih.gov/pubmed/30144293
Maternally-inherited spastic paraplegia: A United Kingdom-based mitochondrial disease cohort study showed that MT-ATP6-related mitochondrial DNA disease is best conceptualized as a mitochondrial disease spectrum disorder
- To read more about “MT-ATP6-related mitochondrial spastic paraplegia”
- Ann Neurol. 2019 Aug;86(2):310-315
Severe hemophilia A: A study analyzed the timing of inhibitor development in more than 1000 previously untreated patients
- To read more about “Hemophilia A”
- Blood. 2019 Jul 18;134(3):317-320
Multiple myeloma: A phase 1b study of daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma demontrasted an overall response rate of 84%
- To read more about “Multiple myeloma”
- Blood. 2019 Aug 1;134(5):421-431
Multiple myeloma: A phase 1b study of isatuximab plus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma demonstrated a potential meaningful clinical activity with an overall response rate of 62%
- To read more about “Multiple myeloma”
- Blood. 2019 Jul 11;134(2):123-133
Multiple myeloma: A European retrospective chart review showed that real-world data could be used to help develop strategies for improving survival
- To read more about “Multiple myeloma”
- Eur J Haematol. 2019 Aug;103(2):107-115
Chronic lymphocytic leukemia: A randomized phase 3 study showed that overall survival and progression free survival were superior with ibrutinib plus rituximab compared to standard chemotherapy in previously untreated patients
- To read more about “B-cell chronic lymphocytic leukemia”
- N Engl J Med. 2019 Aug 1;381(5):432-443
Chronic lymphocytic leukemia: In a real-life cohort study with patient still on ibrutinib after at least three years of treatment, BTK and PLCG2 mutations were detected in 57% and 13% of the next-generation sequencing samples, respectively.
- To read more about “B-cell chronic lymphocytic leukemia”
- Blood. 2019 Aug 15;134(7):641-644
B-cell non-Hodgkin lymphoma: A study showed that CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma were associated with a 2-year progression-free survival of 30%
- To read more about “B-cell non-Hodgkin lymphoma”
- Blood. 2019 Aug 15;134(7):626-635
Follicular lymphoma: A study showed that CD19 CAR-T cell immunotherapy is highly effective in adults with clinically aggressive relapsed or refractory follicular lymphoma with durable remission in a high proportion of patients
- To read more about “Follicular lymphoma”
- Blood (2019): blood.2019000905. Web. 12 Sept2019.
Follicular lymphoma: A randomized phase 2 trial showed that short regimen of rituximab plus lenalidomide in untreated patients improved complete response rate and progression free survival compared to rituximab only
- To read more about “Follicular lymphoma”
- Blood. 2019 Jul 25;134(4):353-362
Hodgkin lymphoma: A phase 2 study showed that brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky stage I/II classical Hodgkin lymphoma without radiation produced a high complete response rate
- To read more about “https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=3739”
- Blood. 2019 Aug 15;134(7):606-613
Biomarkers
Moyamoya angiopathy: Predictors of clinical or cerebral lesion progression in adult
- To read more about “Moyamoya angiopathy”
- Neurology. 2019 Jul 23;93(4):e388-e397
Diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis identified predictors of disease worsening defined by progression of organ damage
- To read more about “Systemic sclerosis”
- Ann Rheum Dis. 2019 Sep;78(9):1242-1248
Sporadic Creutzfeldt-Jakob disease: Cerebrospinal fluid and plasma tau levels were significantly associated with survival time
- To read more about “Sporadic Creutzfeldt-Jakob disease”
- JAMA Neurol. 2019 May 6
Therapeutic Approaches
Localized scleroderma: A study showed that bone morphogenetic protein-6 inhibited fibrogenesis offering treatment options for fibrotic skin disease
- To read more about “Localized scleroderma”
- J Invest Dermatol. 2019 Sep;139(9):1914-1924.e6
Recessive dystrophic epidermolysis bullosa: Efficient gene reframing therapy with CRISPR/Cas9 to a recurrent frameshift mutation in COL7A1
- To read more about “Recessive dystrophic epidermolysis bullosa, generalized intermediate”
- J Invest Dermatol. 2019 Aug;139(8):1711-1721
Chronic lymphocytic leukemia: A study showed that ROR1-targeted delivery of miR-29b induced cell cycle arrest and therapeutic benefit in vivo in a mouse model
- To read more about “B-cell chronic lymphocytic leukemia”
- Blood. 2019 Aug 1;134(5):432-444.
Chronic lymphocytic leukemia: A study showed that inhibition of IGF1R offered efficacious salvage treatment of PI3K-δ inhibitor-resistant tumors in a murine model
- To read more about “B-cell non-Hodgkin lymphoma”
- Blood. 2019 Aug 8;134(6):534-547
Primary cutaneous T-cell lymphoma: A study showed that combined inhibition of Bcl-2 and NFκB synergistically induced cell death
- To read more about “Primary cutaneous T-cell lymphoma”
- Blood 2019 134:445-455
Hepatocellular carcinoma: A study showed the clinical potential of combining sorafenib with GPC3-targeted CAR T cells in mouse models
- To read more about “Hepatocellular carcinoma”
- Mol Ther. 2019 Aug 7;27(8):1483-1494
Glioblastoma: A study showed that acquired temozolomide resistance in MGMT-deficient glioblastoma cells was associated with regulation of DNA repair by DHC2
- To read more about “Glioblastoma”
- Brain. 2019 Aug; 142(8): 2352–2366
Diagnostic Approaches
Systemic lupus erythematosus: A study showed that the presence of anti-NR2 antibodies in patients with systemic lupus erythematosus with fatigue was a helpful diagnostic tool
- To read more about “Systemic lupus erythematosus”
- Ann Rheum Dis. 2019 Sep;78(9):1226-1234
Cholangiocarcinoma: Specific changes in serum concentrations of certain metabolites are useful to differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma and primary sclerosing cholangitis
- To read more about “Cholangiocarcinoma”
- To read more about “Hepatocellular carcinoma”
- To read more about “Primary sclerosing cholangitis”
- Hepatology. 2019 Aug;70(2):547-562
Update on the use of exome sequencing in the diagnosis of fetal abnormalities
- Eur J Med Genet. 2019 Aug;62(8):103663
Unique bioinformatic approach and comprehensive reanalysis improve diagnostic yield of clinical exomes
- Eur J Hum Genet. 2019 Sep;27(9):1398-1405
An algorithm as a diagnostic tool for central ocular motor disorders, also to diagnose rare disorders
- Orphanet J Rare Dis. 2019 Aug 8;14(1):193
The demise of preimplantation genetic testing for aneuploidy in Hungary and its effect on patient care
- Eur J Med Genet. 2019 Aug;62(8):103669
Patient management and therapy
Primary ciliary dyskinesia: A review of a genetic disorder of motile cilia
- To read more about “Primary ciliary dyskinesia”
- Translational Science of Rare Diseases 4 (2019) 51–75
Polycythemia vera: How I treat polycythemia vera
- To read more about “Polycythemia vera”
- Blood. 2019 Jul 25;134(4):341-352
Incontinentia pigmenti: A review of incontinentia pigmenti in adults
- To read more about “Incontinentia pigmenti”
- Am J Med Genet A. 2019 Aug;179(8):1415-1419
Marfan syndrome: Improved clinical history results in expanded natural history
- To read more about “Marfan syndrome”
- Genet Med. 2019 Aug;21(8):1683-1690
Pheochromocytoma and paraganglioma : A review
- To read more about “Sporadic pheochromocytoma/secreting paraganglioma”
- N Engl J Med 2019; 381:552-565
Intellectual and developmental disabilities research centers: Fifty years of scientific accomplishments
- Ann Neurol. 2019 Sep;86(3):332-343
Recommendations
Primary sclerosing cholangitis: British Society of Gastroenterology guidelines for the diagnosis and management
- To read more about “Primary sclerosing cholangitis”
- Gut. 2019 Sep;68(9):1545-1575
Juvenile localised scleroderma: Consensus-based recommendations for the management
- To read more about “Localized scleroderma”
- Ann Rheum Dis. 2019 Aug;78(8):1019-1024
Costello syndrome: Clinical phenotype, genotype, and management guidelines
- To read more about “Costello syndrome”
- Am J Med Genet A. 2019 Sep;179(9):1725-1744
Giant cell arteritis: 2018 EULAR recommendations for a core data set to support observational research and clinical care
- To read more about “Giant cell arteritis”
- Ann Rheum Dis. 2019 Sep;78(9):1160-1166
Epidemiology
Isolated postaxial polydactyly: Epidemiologic characteristics from a multicenter birth defects study
- To read more about “Postaxial polydactyly type A”
- To read more about “Postaxial polydactyly type B”
- Am J Med Genet A. 2019 Aug;179(8):1432-1441
Tuberculosis: Epidemiology of tuberculosis among children and adolescents in the USA, 2007-17: An analysis of national surveillance data
- To read more about “Tuberculosis”
- Lancet Public Health. 2019 Aug 21
Myeloproliferative neoplasms: Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
- To read more about “Myeloproliferative neoplasm”
- Blood. 2019 Aug 1;134(5):469-479
Acute lymphoblastic leukaemia : A report on survival in adult from the Swedish ALL Registry
- Eur J Haematol. 2019 Aug;103(2):88-98
Non-syndromic sacral agenesis: Descriptive and risk factor analysis from the National Birth Defects Prevention Study, 1997-2011
- To read more about “Caudal regression sequence”
- Am J Med Genet A. 2019 Sep;179(9):1799-1814

